Tag: biotech stocks
Biotech Sector ETF (XBI) May Soon Become A Value Buy
The decline in biotech stocks through summer and autumn isn't over just yet. Even so, there may be an opportunity to shop for a...
When Market Bubbles Burst: Biotech Sector Feels The Pain
When The Bubble Bursts…
After reaching 400 in July, the Biotech iShares Sector ETF (IBB) has been exhibiting all the technical hallmarks of a major market...
Biotech ETF (FBT): Broken Trend Line Highlights Crossroads
This past April, I highlighted an important long term trend line support for the Biotech ETF (FBT). The trend line is included on this...
Can Biogen Regain Its Mojo? BIIB Earnings On Tap…
Biogen has lagged the scorching hot biotech group this summer. Why? Well, Wednesday Biogen Idec (BIIB) announced some apparently disappointing data on its Alzheimer's...
The Rotation Report: U.S. Equities Atop Global Stock Markets
As stocks in Germany and China try to work through major stock market corrections, the U.S. market and select sectors look pretty good.
Market sentiment is...
Are Biotech Stocks Nearing Exhaustion… Again?
In early April I wrote a piece arguing that biotech stocks – using the iShares Nasdaq Biotech ETF (IBB) as a proxy – looked to...
Can The Biotech Sector (IBB) Regain Its Swagger?
The once left for dead Biotech Sector has re-awakened. The group is experiencing some of the same ‘this is it, it’s over’ sentiment that...
What’s Next For Biotech Stocks? Watch This Trend Line
There has been a lot of buzz surrounding the recent weakness in the Biotech stocks as traders try to digest the recent bouts of selling...
Why The Biotech Sector ETF (IBB) Is “Distributing” Pain
A few days ago I tweeted that the iShares Nasdaq Biotechnology ETF (IBB) looked to have entered a period of clear “distribution”, meaning that...
Caution: These Two Key Market Leaders May Be Topping
I am a big believer in following market leaders for both investment prospects and indicators. As investments, they can bring big profits. And as...
